We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information on variants of the SARS-CoV-2 virus.
Guidance and support on coronavirus (COVID-19) in Scotland.
Evidence considered by the Scientific Advisory Group for Emergencies (SAGE).
Guidance and support on coronavirus (COVID-19) in Northern Ireland.
Information about COVID-19 and pregnancy from the Royal College of Obstretricians and Gynaecologists (RCOG).
Data on the real-world efficacy of the COVID-19 vaccines.
Guidance and support on coronavirus (COVID-19) in Wales.
How investigators and sponsors should manage clinical trials during COVID-19
Guidance relating to blood clotting, myocarditis and Guillain-Barré Syndrome (GBS) after COVID-19 vaccination.
Summary statistics on the number of defence personnel who have had a COVID-19 test; and for the UK Armed Forces, the number of positive cases of COVID-19.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The official UK government website for data and insights on COVID-19.
Advice and guidance for healthcare practitioners on the health needs of migrant patients.
Guidance for people aged 12 and over whose immune system means they are at higher risk of serious illness if they become infected with COVID-19.
Information about how the Competition and Markets Authority responded to the coronavirus (COVID-19) outbreak.
The MHRA is ready to provide any assistance for clinical trials applications submitted for COVID-19
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Guidance about coronavirus (COVID-19) personal protective equipment (PPE).
On 18 March the Defence Secretary announced new measures to enable armed forces personnel to support public services in response to the coronavirus outbreak.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.